Catalyst Capital Advisors »

Halozyme Therapeutics shares owned by Catalyst Capital Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Catalyst Capital Advisors from 13F filings

Historical chart of Catalyst Capital Advisors investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Catalyst Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Catalyst Capital Advisors

Quarter filed Position value Share count Share price at filing
2012-12-31 $53k 7.8k 6.81
2012-09-30 $36k 4.8k 7.49
2012-06-30 $14k 1.5k 9.09

More positions owned by Catalyst Capital Advisors

Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Msci Usa Min Vol (USMV)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci India Etf (INDA)
Vanguard Index Fds Large Cap Etf (VV)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Index Fds Real Estate Etf (VNQ)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr Rus Mid Cap Etf (IWR)

View all positions for Catalyst Capital Advisors

Top funds holding Halozyme Therapeutics

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Alliancebernstein
Artisan Partners Limited Partnership
Macquarie Group
Geode Capital Management
Jpmorgan Chase & Co
Congress Asset Management
Bank of America Corporation
Arrowpoint Asset Management
Handelsbanken Fonder AB
Invesco

View all funds holding Halozyme Therapeutics